Dr. Timothy Monari Nyarandi, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 332 2nd Ave N, Wahpeton, ND 58075 Phone: 701-642-7000 Fax: 701-642-7055 |
Patrick E Emery, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 332 2nd Ave N, Wahpeton, ND 58075 Phone: 701-642-7000 Fax: 701-642-7055 |
Susan K Nelson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 275 11th St S, Wahpeton, ND 58075 Phone: 701-642-2000 |
Dawn K Pankow, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 275 11th St S, Wahpeton, ND 58075 Phone: 701-642-2000 Fax: 701-671-4106 |
Dr. Winter Marie Ackerman, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 332 2nd Ave N, Wahpeton, ND 58075 Phone: 701-642-7000 Fax: 701-642-7055 |
Robert P Ostmo, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 332 2nd Ave N, Wahpeton, ND 58075 Phone: 701-642-7070 Fax: 701-642-7055 |
Dylan M Torgerson, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 332 2nd Ave N, Wahpeton, ND 58075 Phone: 701-642-7000 |
Dr. Christopher Sue, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 275 11th St S, Wahpeton, ND 58075 Phone: 701-642-2000 |
William M Mayo, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 332 2nd Ave N, Wahpeton, ND 58075 Phone: 701-642-7070 Fax: 701-642-7055 |
Garry A Mislan, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 332 2nd Ave N, Wahpeton, ND 58075 Phone: 701-642-7000 Fax: 701-642-7055 |
Dr. Kristina England, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 275 11th St S, Wahpeton, ND 58075 Phone: 701-642-2000 Fax: 701-671-4106 |
James Edward Halvorson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 332 2nd Ave N, Wahpeton, ND 58075 Phone: 701-642-7000 Fax: 701-642-7000 |
News Archive
Impax Laboratories, Inc. today confirmed that the U.S. Food and Drug Administration (FDA) has granted tentative approval of the Company's Abbreviated New Drug Application (ANDA) for generic version of Opana® ER (oxymorphone hydrochloride) 5, 7.5, 10, 15, 20, 30 and 40 mg tablets.
Improving newborn care in the first month of life is essential for reducing child deaths in developing countries, according to a global update on the Millennium Development Goals (MDGs) released today in the World Health Statistics 2010.
A media comprised of a sandwich of materials, tested by Sandia National Laboratories, is being manufactured into N95-like respirators that could be used in local medical facilities.
A condition that affects the blood, known as idiopathic thrombocytopenic purpura (ITP), may be associated the Oxford-AstraZeneca vaccine in rare cases, research suggests.
› Verified 2 days ago